VCANBIO(SH:600645) Xin Lang Cai Jing·2025-11-20 02:57Core Viewpoint - Zhongyuan Union's stock price has experienced fluctuations, with a year-to-date increase of 36.32% but a recent decline of 6.93% over the past five trading days [2] Company Overview - Zhongyuan Union, established on June 14, 1995, and listed on May 4, 1993, is located in Tianjin Binhai High-tech Zone. The company specializes in cell detection preparation and storage, in vitro diagnostic materials, reagents, and equipment, as well as gene testing services and clinical applications of stem cells and immune cells [2] - The main business revenue composition includes: testing reagents (58.46%), cell detection preparation and storage (26.49%), research reagents (11.86%), gene testing (2.40%), and others (0.79%) [2] Financial Performance - For the period from January to September 2025, Zhongyuan Union achieved operating revenue of 1.092 billion yuan, a year-on-year decrease of 9.41%, and a net profit attributable to shareholders of 108 million yuan, down 19.18% year-on-year [2] - Cumulative cash dividends since A-share listing amount to 37.5405 million yuan, with no dividends distributed in the past three years [3] Shareholder Structure - As of September 30, 2025, the number of shareholders increased by 4.06% to 34,700, with an average of 13,482 circulating shares per person, a decrease of 3.91% [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 15.25 million shares (an increase of 902,300 shares), and Huabao Zhongzheng Medical ETF, holding 10.5688 million shares (a decrease of 1.5141 million shares) [3]